Summary
Cevec Pharmaceuticals GmbH (Cevec) is a biopharmaceutical company that Specializes in the production of tailor-made recombinant glycoproteins and gene therapy vectors. The company utilizes its CAP-Go technology for the production of complexly glycosylated molecules including coagulation factors and other plasma proteins. Its CAP-GT cell lines provide a novel platform for the industrial production of adenoviral vectors, AAV and lentiviral vectors. The company provides CGMP manufacturing, process development, cell line development and contract manufacturing services among others. It out-licenses its expression technology platform and product candidates through partnerships with biotechnology and pharmaceutical companies. Cevec is headquartered in Cologne, Nordrhein-Westfalen, Germany.
Cevec Pharmaceuticals GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
CEVEC Pharma Raises USD4.9 Million in Financing Round 11
Cevec Pharma Raises US$3.6 Million In Extended Series C Financing 12
CEVEC Pharma Raises US$8.6 Million In Series C Financing 14
Partnerships 15
Catalent Pharma Enters Into Co-Development Agreement With Cevec Pharma 15
CEVEC Pharma Enters Into Technology Integration Agreement With Catalent Pharma 16
Licensing Agreements 17
NewLink Genetics Enters into Licensing Agreement with Cevec Pharma 17
Paragon Bioservices Enters into Licensing Agreement with CEVEC Pharma 17
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 18
BioLamina Enters into Licensing Agreement with Cevec Pharma 19
CellGenix Enters into Licensing Agreement with Cevec Pharma 20
CEVEC Pharma Enters into Licensing Agreement with Genethon 21
CEVEC Pharma Enters into Licensing Agreement with Biotest 22
Vibalogics Enters into Licensing Agreement with Cevec Pharma for CAP Technology 23
Cevec Pharma Enters Into Licensing Agreement With Vakzine Projekt Management For CMV Dense Body Technology 24
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 25
Cevec Pharma Enters Into Licensing Agreement With CCS Cell Culture Service 26
CEVEC Pharma Announces Licensing Agreement With Paragon Bioservices For Proprietary Human Cell Lines 26
Cevec Pharmaceuticals GmbH - Key Competitors 28
Key Employees 29
Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31
List of Tables
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Key Facts 1
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cevec Pharmaceuticals GmbH, Deals By Therapy Area, 2011 to YTD 2017 8
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CEVEC Pharma Raises USD4.9 Million in Financing Round 11
Cevec Pharma Raises US$3.6 Million In Extended Series C Financing 12
CEVEC Pharma Raises US$8.6 Million In Series C Financing 14
Catalent Pharma Enters Into Co-Development Agreement With Cevec Pharma 15
CEVEC Pharma Enters Into Technology Integration Agreement With Catalent Pharma 16
NewLink Genetics Enters into Licensing Agreement with Cevec Pharma 17
Paragon Bioservices Enters into Licensing Agreement with CEVEC Pharma 17
Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 18
BioLamina Enters into Licensing Agreement with Cevec Pharma 19
CellGenix Enters into Licensing Agreement with Cevec Pharma 20
CEVEC Pharma Enters into Licensing Agreement with Genethon 21
CEVEC Pharma Enters into Licensing Agreement with Biotest 22
Vibalogics Enters into Licensing Agreement with Cevec Pharma for CAP Technology 23
Cevec Pharma Enters Into Licensing Agreement With Vakzine Projekt Management For CMV Dense Body Technology 24
Cevec Pharma Enters Into Licensing Agreement With Yuhan To Develop Therapeutic Proteins 25
Cevec Pharma Enters Into Licensing Agreement With CCS Cell Culture Service 26
CEVEC Pharma Announces Licensing Agreement With Paragon Bioservices For Proprietary Human Cell Lines 26
Cevec Pharmaceuticals GmbH, Key Competitors 28
Cevec Pharmaceuticals GmbH, Key Employees 29
Cevec Pharmaceuticals GmbH, Subsidiaries 30
List of Figures
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cevec Pharmaceuticals GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
